The increasing field of immunotherapy relies heavily on recombinant mediator technology, and a detailed understanding of individual profiles is paramount for optimizing experimental design and therapeutic efficacy. https://dmozbookmark.com/story20949382/understanding-recombinant-mediator-profiles-il-1a-il-1b-il-2-and-il-3